PokeAcells mission is to provide curative treatment to solid tumor patients. Composing science and biology to create a better future for patients with no alternative treatment today is the heartbeat of our company.
PokeAcell is a spin out of DTU Health Technologies based on the distinct expertise of our CSO Prof. Sine R. Hadrup, PhD., and her highly recognized scientific work within tumor antigen mapping and T cell detection. With our experienced founder team and world leading advisors PokeAcell aim to provide curative treatment to solid tumor patients by being leaders in innovative T cell therapies.